Protamine-induced acute thrombosis in a post-TAVR patient: A word of caution
Source : https://www.sciencedirect.com/science/article/abs/pii/S1553838922003001?via=ihub
Available online 10 June 2022 Major vascular complications after sulfate (PS) that was administered to mitigate a bleeding complication post-failure of a transcatheter aortic valve replacement (TAVR) are a pertinent...
Conclusion/Relevance: PS should be used cautiously for the prevention or management of bleeding-site complications following TAVR. The patient described in this case has consented to having his case described in this manuscript.
Leaflet thickening and motion after transcatheter aortic valve replacement: Design and rationale of the Rotterdam edoxaban trial
Source : https://www.sciencedirect.com/science/article/pii/S1553838922003050?via=ihub
Hypo-attenuated leaflet thickening occurs in 15% of TAVR patients * Impact of HALT is unsettled * Factor Xa inhibition may reduce HALT incidence Multislice computed tomography (MSCT) may reveal hypo-attenuated...
Conclusion: The REDOX trial will investigate the short-term effect of an Xa-inhibitor on the incidence of HALT after TAVR.
Bioprosthetic valve dysfunction and failure after TAVI in bicuspid aortic valve stenosis during one-year follow-up according to VARC-3 - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/35767098/
There is critical evidence of early BVD after TAVI in BAV during one-year FU in one-third of patients, also lowering device success. The most frequently observed bioprosthetic valve dysfunction was...
Conclusion: There is critical evidence of early BVD after TAVI in BAV during one-year FU in one-third of patients, also lowering device success. The most frequently observed bioprosthetic valve dysfunction was NSVD due to patient prosthesis mismatch following TAVI with a balloon-expandable valve.
Infective Endocarditis Complicated With Septic Embolic Stroke After Transcatheter Aortic Valve Implantation: A Case Report
Transcatheter aortic valve implantation (TAVI) is a relatively novel procedure developed for aortic stenosis (AS) management in patients with moderate to high surgical risk, especially the elderly with multiple comorbidities....
Conclusions: For patients newly diagnosed with sAS, we observed differences in rates of cardiac specialist follow‐up and AVR and risk of mortality between primary care provider‐ versus cardiologist‐managed patients with sAS. In addition, a lower likelihood of receiving follow‐up and AVR was independently associated with higher...